Evidence

CSP algorithm performance

The CSP algorithm was developed and tested on a total of 23,029 patients from 47 countries.

When using the 11.5% cutoff to determine whether patients were high risk, the CSP algorithm: correctly detected 80.5% of the patients with an eGFR below 60 as high risk, identified 53.2% as being high risk, and increased the positive predictive value (relatively) by 51.5%, on average, globally.

 

These results translate to the CSP algorithm offering improved efficiency of identifying patients with an eGFR below 60, or a reduced cost to identify the same number of patients (Figure right).

Click to expand

Peer-reviewed publications

RCP
Future Healthcare Journal

Development of minimal resource pre-screening tools for chronic kidney disease in people with type 2 diabetes

DOI: https://doi.org/10.7861/fhj.2022-0020

November 2022

click to open

Scientific presentations

Click to expand
ASN Logo

Global Validation of a Minimal-Resource Pre-Screening Model for Reduced Kidney Function in Patients With Type 2 Diabetes

Journal of the American Society of Nephrology33 (Abstract Supplement), 681 (2022).

Click to open
EASD Logo

Minimal resource pre-screening tools for chronic kidney disease in people with type 2 diabetes: a global validation study

September 2022

Resources

Portuguese (Brazil)

Acelerando a via de tratamento para pacientes

Spanish (Mexico)

Acelerar la vía de tratamiento para los pacientes